Discontinued — last reported Q4 '25
Eli Lilly Net Income increased by 18.9% to $6.64B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 50.5%, from $4.41B to $6.64B. Over 4 years (FY 2021 to FY 2025), Net Income shows an upward trend with a 38.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates growing profitability and potential for dividends or reinvestment, while a decrease suggests rising costs or falling sales.
The final profit remaining after all operating expenses, interest, taxes, and non-operating items have been deducted fro...
Peer companies in the software and cloud sectors typically trade at multiples of this figure, though it can be impacted by one-time tax adjustments or non-cash charges.
is_net_income| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.39B | $1.11B | $1.73B | $1.90B | $952.50M | $1.45B | $1.94B | $1.34B | $1.76B | -$57.40M | $2.19B | $2.24B | $2.97B | $970.30M | $4.41B | $2.76B | $5.66B | $5.58B | $6.64B |
| QoQ Change | — | -20.1% | +55.5% | +10.2% | -49.9% | +52.4% | +33.5% | -30.6% | +31.1% | -103.3% | >999% | +2.4% | +32.3% | -67.3% | +354.5% | -37.4% | +105.1% | -1.4% | +18.9% |
| YoY Change | — | — | — | — | -31.5% | +30.8% | +12.3% | -29.3% | +85.1% | -104.0% | +13.0% | +66.8% | +68.3% | >999% | +101.4% | +23.0% | +90.8% | +475.3% | +50.5% |
We use cookies for analytics. See our Privacy and Cookie Policy.